Elena Volkov, PA
Physician Assistant · Pikesville, MDNPI 1750419917
Payments from drug & device makers
Across 313 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$799
- Sanofi-aventis U.S. LLC$702
- Novo Nordisk$688
- Pfizer$410
- Bayer$341
- plus $2K from 24 others
What the payments were for
- Food & beverage$6,575100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,304 |
| AstraZeneca | 34 | $799 |
| Sanofi-aventis U.S. LLC | 7 | $702 |
| Novo Nordisk | 55 | $688 |
| Pfizer | 27 | $410 |
| Bayer | 12 | $341 |
| Lilly USA, LLC | 24 | $285 |
| GSK | 9 | $217 |
| Astellas Pharma US Inc | 5 | $216 |
| Abbott | 6 | $215 |
| Exact Sciences | 4 | $192 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $179 |
| Amgen(2 entities) | 4 | $171 |
| Corcept Therapeutics | 1 | $125 |
| Merck | 5 | $119 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Kowa Pharmaceuticals America, Inc. | 6 | $87 |
| Boehringer Ingelheim | 5 | $86 |
| Novartis | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Sanofi | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$309
- UBRELVY$244
- TZIELD$163
- TOUJEO$138
- Korlym$125
- QULIPTA$124
- Cologuard Collection Kit$124
- Veozah$122
- FreeStyle Libre$122
- Kerendia$121
- AIRSUPRA$118
- TRELEGY ELLIPTA$114
- BREZTRI$114
- KRYSTEXXA$113
- Inspire$101
How this compares
$6,575 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 117 | $157,971 |
| EliquisApixaban | 220 | $151,935 |
| FarxigaDapagliflozin Propanediol | 113 | $94,948 |
| JardianceEmpagliflozin | 106 | $78,987 |
| LinzessLinaclotide | 127 | $74,095 |
| OzempicSemaglutide | 25 | $45,314 |
| VascepaIcosapent Ethyl | 124 | $43,168 |
| XareltoRivaroxaban | 48 | $36,203 |
| TradjentaLinagliptin | 49 | $28,899 |
| MyrbetriqMirabegron | 43 | $27,016 |
| ZenpepLipase/Protease/Amylase | 18 | $22,141 |
| JanumetSitagliptin Phos/Metformin Hcl | 20 | $21,305 |
| EntrestoSacubitril/Valsartan | 26 | $17,857 |
| MounjaroTirzepatide | 11 | $17,370 |
| Rosuvastatin Calcium | 853 | $17,061 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess, Restasis | $1,304 | $239,424255 claims |
| PfizerEliquis | $410 | $151,935220 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto Xr, Combivent Respimat | $86 | $126,405191 claims |
| AstraZenecaFarxiga | $799 | $94,948113 claims |
| Novo NordiskOzempic | $688 | $45,31425 claims |
| MerckJanumet, Januvia | $119 | $38,02649 claims |
| Astellas Pharma US IncMyrbetriq | $216 | $27,01643 claims |
| NovartisEntresto | $62 | $17,85726 claims |
| Lilly USA, LLCMounjaro | $285 | $17,37011 claims |
| GSKBreo Ellipta | $217 | $11,64624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Pikesville
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.